Physician

Lori Ann Ricklefs, D.O.

According to 2025 Medicare claims, Lori Ricklefs, D.O. (NPI: 1376864199) practices osteopathic manipulative therapy in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Nash, NC. This provider's primary affiliated billing organization is GENERATIONS FAMILY PRACTICE, PA (NPI: 1972194868; TIN: 75-3210435) and primary practice location at 27804-6023. Ricklefs is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Ricklefs' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 277 traditional Medicare patients, billed 1,205 HCPCS/CPT codes, and received $50,815 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 11,049 prescription claims across 815 beneficiaries totaling $1,389,573 in drug costs, led by Ozempic (Semaglutide). DME data shows 45 claims. Open Payments data shows 69 records totaling $1,324. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $131,775 to $1,389,573. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $902 and ending at $3,896.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	261	2,156	$85,542
2016	269	2,086	$84,336
2017	331	2,096	$96,839
2018	352	2,016	$91,589
2019	453	2,698	$121,018
2020	937	7,754	$234,228
2021	610	5,161	$144,954
2022	276	1,027	$67,850
2023	325	1,219	$59,331
2024	277	1,205	$50,815

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	232	2,940	$131,775
2016	264	4,241	$229,154
2017	316	4,795	$261,416
2018	321	5,107	$268,474
2019	349	5,682	$343,281
2020	373	6,358	$406,790
2021	377	5,224	$402,210
2022	494	2,918	$347,056
2023	684	6,871	$878,112
2024	815	11,049	$1,389,573

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	47	$577
2016	13	60	$809
2017	13	42	$407
2018	13	70	$1,683
2019	13	73	$2,825
2020	29	70	$567
2021	32	93	$729
2022	11	36	$307
2023	N/R	N/R	N/R
2024	12	45	$747

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	26	26	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	244	468	$77
G0444	Annual depression screening, 5 to 15 minutes	22	22	$17
99211	Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional	25	190	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	55	59	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	153	6,936	$229,414
Eliquis	Apixaban	144	7,256	$134,214
Rybelsus	Semaglutide	57	3,090	$96,598
Farxiga	Dapagliflozin Propanediol	90	4,422	$81,026
Jardiance	Empagliflozin	66	3,813	$75,323

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	23	$368
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	11	$356
A4259	Lancets, per box of 100	N	N/R	11	$23

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,324	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lori Ann Ricklefs, D.O.?

Tedicare shows public-source Medicare data for Lori Ann Ricklefs, D.O. (NPI 1376864199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lori Ann Ricklefs, D.O. have ACO affiliation data?

Lori Ann Ricklefs, D.O. is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Lori Ann Ricklefs, D.O.?

Lori Ann Ricklefs, D.O. is linked to GENERATIONS FAMILY PRACTICE, PA (billing NPI 1972194868) in the available physician profile data.

Does Lori Ann Ricklefs, D.O. have Open Payments data?

Lori Ann Ricklefs, D.O. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.